(CSSLI) iShares SLI (CH) - Ratings and Ratios
Financials, Pharmaceuticals, Consumer Goods
Description: CSSLI iShares SLI (CH)
The iShares SLI ETF (CH) tracks the Morningstar Switzerland TME NR CHF Index, providing investors with exposure to the Swiss equity market. As a Switzerland-focused ETF, it is designed to capture the performance of the countrys top companies.
From a technical analysis perspective, the ETF is currently trading at 209.00 CHF, slightly below its 20-day Simple Moving Average (SMA) of 211.91. The 50-day and 200-day SMAs are at 208.52 and 208.40, respectively, indicating a relatively stable trend. The Average True Range (ATR) is 2.21, representing a daily volatility of 1.06%. Given the current price action and moving averages, we can expect a potential breakout or consolidation in the near term.
Fundamentally, the ETF has a total Assets Under Management (AUM) of 669.63 million CHF, indicating a moderate level of investor interest. As the ETF is tracking a Switzerland-focused index, its performance is closely tied to the countrys economic and market conditions.
Using a combination of technical and fundamental analysis, we can forecast that the iShares SLI ETF (CH) may experience a moderate upside in the next few weeks, driven by a potential breakout above its 20-day SMA. If the ETF can sustain a move above 212.00, it may target the 52-week high of 223.31. However, if it fails to break out, it may consolidate around the 208-210 range, supported by its 50-day and 200-day SMAs. A key driver of this forecast is the overall trend in the Swiss equity market, as well as any potential economic or market catalysts that may impact the ETFs underlying holdings.
Additional Sources for CSSLI ETF
CSSLI ETF Overview
Market Cap in USD | 868m |
Category | Switzerland Equity |
TER | 0.35% |
IPO / Inception | 2007-06-29 |
CSSLI ETF Ratings
Growth Rating | 48.2 |
Fundamental | - |
Dividend Rating | 50.6 |
Rel. Strength | -10 |
Analysts | - |
Fair Price Momentum | 198.86 CHF |
Fair Price DCF | - |
CSSLI Dividends
Dividend Yield 12m | 1.90% |
Yield on Cost 5y | 2.67% |
Annual Growth 5y | 5.95% |
Payout Consistency | 96.4% |
Payout Ratio | % |
CSSLI Growth Ratios
Growth Correlation 3m | 28.4% |
Growth Correlation 12m | 42.9% |
Growth Correlation 5y | 69.5% |
CAGR 5y | 7.23% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 1.06 |
Alpha | -7.71 |
Beta | 0.592 |
Volatility | 10.56% |
Current Volume | 2.1k |
Average Volume 20d | 2.9k |
Stop Loss | 203.9 (-3%) |
As of July 16, 2025, the stock is trading at CHF 210.20 with a total of 2,067 shares traded.
Over the past week, the price has changed by +0.34%, over one month by -0.71%, over three months by +6.07% and over the past year by +1.48%.
Partly, yes. Based on ValueRay´s Analyses, iShares SLI (CH) (SW:CSSLI) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.18 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSSLI is around 198.86 CHF . This means that CSSLI is currently overvalued and has a potential downside of -5.39%.
iShares SLI (CH) has no consensus analysts rating.
According to our own proprietary Forecast Model, CSSLI iShares SLI (CH) will be worth about 223.1 in July 2026. The stock is currently trading at 210.20. This means that the stock has a potential upside of +6.14%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 223.1 | 6.1% |